The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)
News | Peripheral Artery Disease (PAD)
Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives
News | Cardiac Imaging
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s ...

Home July 11, 2023
Home
US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA
News | Heart Failure
Sequana Medical Announces First Patient Enrolled in MOJAVE

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home July 10, 2023
Home
Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not had a cardiovascular event but are at an increased risk of heart
News | Pharmaceuticals
FDA Approves Expanded Indication for Leqvio

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...

Home July 10, 2023
Home
Innovative platform designed for more personalized, tailored management of heart failure patients
News | Heart Failure
Adona Medical’s Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference

July 10, 2023 — Adona Medical, a Shifamed portfolio company that aims to deliver advanced interatrial shunting and ...

Home July 10, 2023
Home
Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials
Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA
The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

Home July 10, 2023
Home
HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF).
News | Heart Failure
CMS Establishes HCPCS code for Ultromics EchoGo Heart Failure

July 7, 2023 — Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and ...

Home July 07, 2023
Home
Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke
News | Atrial Fibrillation
Reduced Levels of FKBP5 Promote Atrial Fibrillation

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...

Home July 07, 2023
Home
The goal of the new initiative is to build a national effort to diagnose and treat many more children
News | Pediatric Cardiology
A Model for Africa: Côte d’Ivoire Health Ministry Announces New Initiative to Become Self-Sufficient in Pediatric Cardiology Surgery

July 7, 2023 — Launched by Mitrelli Group, Menomadin Foundation, Save a Child’s Heart, Côte d’Ivoire Health Ministry and ...

Home July 07, 2023
Home
The Amvia Edge pacemaker platform introduces always-on, automatic MR detection algorithm to fully streamline MRI workflow
News | Pacemakers
BIOTRONIK Receives FDA Approval For Next-Generation Family of Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

Home July 06, 2023
Home
Leadless pacemakers provide a new minimally invasive option that will revolutionize care for more people in the U.S. who need pacing to treat a variety of slow or abnormal heart rhythms
News | Pacemakers
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker

July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...

Home July 05, 2023
Home
AI/AN women have more risk factors for poor heart health, such as high rates of Type 2 diabetes, obesity and smoking, and increased exposure to trauma and violence, according to a new American Heart Association scientific statement
News | ECG Monitoring Services
Heart Health is Sub-optimal Among American Indian/Alaska Native Women, Supports Needed

July 5, 2023 — Heart health risks emerge early in life in American Indian/Alaska Native (AI/AN) women and are increased ...

Home July 05, 2023
Home
UM School of Medicine faculty develop tool to assess risks earlier in vulnerable patients
News | Cardiovascular Clinical Studies
New Study Highlights Dangers of Cumulative Exposure to Cardiovascular Risks and Need for Earlier Primary Prevention Strategies

July 5, 2023 — With heart disease the most common cause of death worldwide, researchers have attempted to quantify how ...

Home July 05, 2023
Home
News | ASE
Study Finds More Accurate Pacemaker Placement with 3D Echocardiography

July 5, 2023 — Research presented during the American Society of Echocardiography’s 34th Annual Scientific Sessions, ASE ...

Home July 05, 2023
Home
News | Cardiovascular Business
Happy 4th of July from DAIC

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now